Elevance Health saw its rating drop from “strong-buy” to “hold” by Baird R W, putting a speed bump in its investor love story. Other analysts, however, aren’t hitting the brakes quite yet—many still ...

High Medicare Advantage spending continues to dog major carriers such as Elevance Health and UnitedHealth Group.

Baird notes Elevance Health (ELV) pre-announced a Q1 earnings beat with adjusted EPS of $11.97 vs. $11.62 implied guide, vs. $11.32 street, vs.

Elevance continues to expect its Medicare Advantage program to hit 2.2 million to 2.25 million members in 2025, and for adjusted earnings to be $34.15 to $34.85 a share.

CVS, Humana and Elevance shares are moving lower on Thursday after UnitedHealth reported earnings prior to the market opening.